Inhibitory sites on sodium- and potassium-activated adenosine triphosphatase for chlorpromazine free radical and ouabain.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001921:Brain / Q000201:enzymology; D002746:Chlorpromazine / Q000494:pharmacology*; D005609:Free Radicals; D008274:Magnesium; D008297:Male; D008861:Microsomes / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D012965:Sodium Chloride / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000378:metabolism; D014316:Tritium
D001565:Benzoates; D005609:Free Radicals; D013438:Sulfhydryl Compounds; D014316:Tritium; D012965:Sodium Chloride; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium; D002746:Chlorpromazine